Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
Location: United States, Pennsylvania, Lower Gwynedd Township
Employees: 11-50
Total raised: $55M
Investors 2
| Date | Name | Website |
| - | New Allian... | nac-capita... |
| - | The Innova... | innovation... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.11.2021 | Series B | $35M | - |
| 28.03.2021 | Series A | $20M | - |
Mentions in press and media 5
| Date | Title | Description |
| 20.11.2021 | Tavotek Biotherapeutics Closes $35M Series B Financing | Tavotek Biotherapeutics, a Lower Gwynedd PA-based biotech company, raised $35M in Series B funding. The round was led by CS Capital with participation from Fontus Capital. The company intends to use the funds to accelerate: the Phase 1 clin... |
| 19.11.2021 | Tavotek Biotherapeutics Announces Completion of Round B Financing with $35 Million | LOWER GWYNEDD, Penn., Nov. 19, 2021 /PRNewswire/ -- Tavotek Biotherapeutics, a fast-growing biotech company, announces it has raised $35M in Round B financing. CS Capital, a leading private equity fund manager in China, led this finance rou... |
| 28.03.2021 | Tavotek Biotherapeutics Raises Over $20M in Series A1 and A2 Financing | Tavotek Biotherapeutics, a Lower Gwynedd, PA-based a biopharmaceutical company, raised over $20M in Round A1 and Round A2 financing in the preceding two months. YuanBio Venture Capital led the A1 finance round followed by Oriza Holdings, Mi... |
| 22.03.2021 | Tavotek Biotherapeutics Snares $20M in Series A | LOWER GWYNEDD, PA, Tavotek Biotherapeutics has raised over $20M in Round A1 and Round A2 financing. >> Click here for more funding data on Tavotek Biotherapeutics >> To export Tavotek Biotherapeutics funding data to PDF and ... |
| 22.03.2021 | Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing with over $20 Million Dollars | LOWER GWYNEDD, Pennsylvania, March 22, 2021 /PRNewswire/ -- Tavotek Biotherapeutics announces it has raised over $20M in Round A1 and Round A2 financing in the preceding two months. YuanBio Venture Capital led the A1 finance round followed ... |